Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Mechanisms of Disease: environmental factors in the pathogenesis of rheumatic disease

Nature Clinical Practice Rheumatology volume 3, pages 172–180 (2007)Cite this article

Abstract

Most rheumatic diseases are complex disorders for which pathogenetic mechanisms are poorly understood. Nonetheless, increasing evidence suggests that many of these illnesses result from one or more specific environmental exposures in genetically susceptible individuals. Although much progress has been made over the past few decades in advancing our knowledge of the genetics of rheumatic diseases, few studies have assessed environmental features and understanding of which exposures are important in pathogenesis remains limited. In this article, we review the difficulties inherent in deciphering the interacting environmental and genetic risk factors for rheumatic diseases, the current state of knowledge of infectious and noninfectious risk factors, possible mechanisms by which environmental exposures might induce pathologic processes and future directions. The advances in technologies and statistical approaches, development of collaborating consortia and focused resources that have resulted in the explosion of genetic information must now be applied to environmental studies so we can eventually interrupt pathogenesis before the onset of disease and transform the practice of medicine from curative to pre-emptive paradigms.

Key Points

  • Complementary lines of evidence point to the role of environmental factors in the pathogenesis of rheumatic diseases

  • In addition to well-described cases of drug-induced disease, epidemiologic data support a role for inhaled silica, solvents, pesticides, tobacco smoke and DNA viruses in triggering many rheumatic diseases

  • Mechanisms are ill-defined for all environmentally-associated rheumatic diseases

  • Integrated collaborative approaches, focused resources and better tools, including validated exposure biomarkers and questionnaires, are needed to define additional environmental risk factors and, ultimately, prevent the development of certain forms of rheumatic disease

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Possible phenotypes of rheumatic diseases resulting from different gene–environment interactions

Similar content being viewed by others

References

  1. Miller FW et al. (2000) Approaches for identifying and defining environmentally associated rheumatic disorders. Arthritis Rheum 43: 243–249

    Article  CAS  Google Scholar 

  2. Rodriguez-Reyna TS and Alarcon-Segovia D (2006) The different faces of shared autoimmunity. Autoimmun Rev 5: 86–88

    Article  CAS  Google Scholar 

  3. Mackay IR (2005) The etiopathogenesis of autoimmunity. Semin Liver Dis 25: 239–250

    Article  Google Scholar 

  4. van der Helm-van Mil AH et al. (2005) Understanding the genetic contribution to rheumatoid arthritis. Curr Opin Rheumatol 17: 299–304

    Article  Google Scholar 

  5. Sarzi-Puttini P et al. (2005) Drug-induced lupus erythematosus. Autoimmunity 38: 507–518

    Article  CAS  Google Scholar 

  6. Bramwell B (1914) Diffuse scleroderma: its frequency and occurrence in stonemasons; its treatment by fibrinolysin: elevations of temperature due to fibrinolysin injections. Edinburg Med J 12: 387

    Google Scholar 

  7. Calvert GM et al. (2003) Occupational silica exposure and risk of various diseases: an analysis using death certificates from 27 states of the United States. Occup Environ Med 60: 122–129

    Article  CAS  Google Scholar 

  8. Stolt P et al. (2003) Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis 62: 835–841

    Article  CAS  Google Scholar 

  9. Parks CG et al. (2002) Occupational exposure to crystalline silica and risk of systemic lupus erythematosus: A population-based, case-control study in the Southeastern United States. Arthritis Rheum 46: 1840–1850

    Article  Google Scholar 

  10. Diot E et al. (2002) Systemic sclerosis and occupational risk factors: a case-control study. Occup Environ Med 59: 545–549

    Article  CAS  Google Scholar 

  11. Bovenzi M et al. (2004) A case-control study of occupational exposures and systemic sclerosis. Int Arch Occup Environ Health 77: 10–16

    Article  Google Scholar 

  12. Nuyts GD et al. (1995) Wegener granulomatosis is associated to exposure to silicon compounds: a case-control study. Nephrol Dial Transplant 10: 1162–1165

    Article  CAS  Google Scholar 

  13. Hogan SL et al. (2001) Silica exposure in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and lupus nephritis. J Am Soc Nephrol 12: 134–142

    CAS  PubMed  Google Scholar 

  14. Gregorini G et al. (1993) Association between silica exposure and necrotizing crescentic glomerulonephritis with p-ANCA and anti-MPO antibodies: a hospital-based case-control study. Adv Exp Med Biol 336: 435–440

    Article  CAS  Google Scholar 

  15. Lane SE et al. (2003) Are environmental factors important in primary systemic vasculitis? A case-control study. Arthritis Rheum 48: 814–823

    Article  Google Scholar 

  16. De Roos AJ et al. (2005) Rheumatoid arthritis among women in the agricultural health study: risk associated with farming activities and exposures. Ann Epidemiol 15: 762–770

    Article  Google Scholar 

  17. Nietert PJ and Silver RM (2000) Systemic sclerosis: environmental and occupational risk factors. Curr Opin Rheumatol 12: 520–526

    Article  CAS  Google Scholar 

  18. Sverdrup B et al. (2005) Association between occupational exposure to mineral oil and rheumatoid arthritis: results from the Swedish EIRA case-control study. Arthritis Res Ther 7: R1296–R1303

    Article  CAS  Google Scholar 

  19. Cooper GS et al. (2004) Occupational risk factors for the development of systemic lupus erythematosus. J Rheumatol 31: 1928–1933

    PubMed  Google Scholar 

  20. Han SH (2004) Extrahepatic manifestations of chronic hepatitis B. Clin Liver Dis 8: 403–418

    Article  Google Scholar 

  21. Anzilotti C et al. (2006) Antibodies to Viral Citrullinated Peptide in Rheumatoid Arthritis. J Rheumatol 33: 647–651

    CAS  PubMed  Google Scholar 

  22. Parks CG et al. (2005) Association of Epstein-Barr virus with systemic lupus erythematosus: Effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype. Arthritis Rheum 52: 1148–1159

    Article  CAS  Google Scholar 

  23. Yu SF et al. (2005) Detecting Epstein-Barr virus DNA from peripheral blood mononuclear cells in adult patients with systemic lupus erythematosus in Taiwan. Med Microbiol Immunol (Berlin) 194: 115–120

    Article  CAS  Google Scholar 

  24. Rider JR et al. (1997) Human cytomegalovirus infection and systemic lupus erythematosus. Clin Exp Rheumatol 15: 405–409

    CAS  PubMed  Google Scholar 

  25. Pope JE et al. (2004) Close association of herpes zoster reactivation and systemic lupus erythematosus (SLE) diagnosis: case-control study of patients with SLE or noninflammatory nusculoskeletal disorders. J Rheumatol 31: 274–279

    PubMed  Google Scholar 

  26. Cooper GS et al. (2002) Risk factors for development of systemic lupus erythematosus: allergies, infections, and family history. J Clin Epidemiol 55: 982–989

    Article  Google Scholar 

  27. Strom BL et al. (1994) Shingles, allergies, family medical history, oral contraceptives, and other potential risk factors for systemic lupus erythematosus. Am J Epidemiol 140: 632–642

    Article  CAS  Google Scholar 

  28. James JA et al. (2001) Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum 44: 1122–1126

    Article  CAS  Google Scholar 

  29. James JA et al. (1997) An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 100: 3019–3026

    Article  CAS  Google Scholar 

  30. Caliskan R et al. (2005) The relationship between arthritis and human parvovirus B19 infection. Rheumatol Int 26: 7–11

    Article  CAS  Google Scholar 

  31. Hajeer AH et al. (1994) Influence of previous exposure to human parvovirus B19 infection in explaining susceptibility to rheumatoid arthritis: an analysis of disease discordant twin pairs. Ann Rheum Dis 53: 137–139

    Article  CAS  Google Scholar 

  32. Oguz F et al. (2002) Parvovirus B19 in the acute arthropathies and juvenile rheumatoid arthritis. J Paediatr Child Health 38: 358–362

    Article  CAS  Google Scholar 

  33. Mamyrova G et al. (2005) Parvovirus B19 and onset of juvenile dermatomyositis. JAMA 294: 2170–2171

    CAS  PubMed  Google Scholar 

  34. Lyon MG et al. (1989) Predisposing factors in polymyositis-dermatomyositis: results of a nationwide survey. J Rheumatol 16: 1218–1224

    CAS  PubMed  Google Scholar 

  35. Koch MJ et al. (1976) Childhood polymyositis: a case-control study. Am J Epidemiol 104: 627–631

    Article  CAS  Google Scholar 

  36. Grimes DA et al. (1985) Systemic lupus erythematosus and reproductive function: a case-control study. Am J Obstet Gynecol 153: 179–186

    Article  CAS  Google Scholar 

  37. Minami Y et al. (1993) Female systemic lupus erythematosus in Miyagi Prefecture, Japan: a case-control study of dietary and reproductive factors. Tohoku J Exp Med 169: 245–252

    Article  CAS  Google Scholar 

  38. Nagata C et al. (1995) Systemic lupus erythematosus: a case-control epidemiologic study in Japan. Int J Dermatol 34: 333–337

    Article  CAS  Google Scholar 

  39. Cooper GS et al. (2002) Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study. Arthritis Rheum 46: 1830–1839

    Article  CAS  Google Scholar 

  40. Sanchez-Guerrero J et al. (1997) Past use of oral contraceptives and the risk of developing systemic lupus erythematosus. Arthritis Rheum 40: 804–808

    Article  CAS  Google Scholar 

  41. Bengtsson AA et al. (2002) Risk factors for developing systemic lupus erythematosus: a case-control study in southern Sweden. Rheumatology (Oxford) 41: 563–571

    Article  CAS  Google Scholar 

  42. Okada S et al. (2003) Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease. Arthritis Rheum 48: 2285–2293

    Article  Google Scholar 

  43. Howson CP et al. (1991) Adverse Effects of Pertussis and Rubella Vaccines: A Report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines. Washington, DC: National Academies Press

    Google Scholar 

  44. Cooper GS and Parks CG (2004) Occupational and environmental exposures as risk factors for systemic lupus erythematosus. Curr Rheumatol Rep 6: 367–374

    Article  Google Scholar 

  45. Klareskog L et al. (2006) A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 54: 38–46

    Article  CAS  Google Scholar 

  46. Padyukov L et al. (2004) A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum 50: 3085–3092

    Article  CAS  Google Scholar 

  47. Pattison DJ et al. (2004) Dietary risk factors for the development of inflammatory polyarthritis: evidence for a role of high level of red meat consumption. Arthritis Rheum 50: 3804–3812

    Article  Google Scholar 

  48. Merlino LA et al. (2004) Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 50: 72–77

    Article  CAS  Google Scholar 

  49. Herrmann M et al. (2000) Stress and rheumatic diseases. Rheum Dis Clin North Am 26: 737–763, viii

    Article  CAS  Google Scholar 

  50. Sarkar K and Miller FW (2004) Possible roles and determinants of microchimerism in autoimmune and other disorders. Autoimmun Rev 3: 454–463

    Article  CAS  Google Scholar 

  51. Leff RL et al. (1988) Epidemiology of adult idiopathic inflammatory myopathy: A distinct clinical onset in patients with anti-Jo-1 antibodies. Arthritis Rheum 31: D113–S121

  52. Kuhn A and Beissert S (2005) Photosensitivity in lupus erythematosus. Autoimmunity 38: 519–529

    Article  CAS  Google Scholar 

  53. Furukawa F et al. (1990) Binding of antibodies to the extractable nuclear antigens SS-A/Ro and SS-B/La is induced on the surface of human keratinocytes by ultraviolet light (UVL): implications for the pathogenesis of photosensitive cutaneous lupus. J Invest Dermatol 94: 77–85

    Article  CAS  Google Scholar 

  54. Ueki A et al. (1994) Polyclonal human T-cell activation by silicate in vitro. Immunology 82: 332–335

    CAS  PubMed  PubMed Central  Google Scholar 

  55. Koeger AC et al. (1995) Silica-associated connective tissue disease. A study of 24 cases. Medicine (Baltimore) 74: 221–237

    Article  CAS  Google Scholar 

  56. Guilherme L et al. (2005) Molecular pathogenesis of rheumatic fever and rheumatic heart disease. Expert Rev Mol Med 7: 1–15

    Article  Google Scholar 

  57. McClain MT et al. (2005) Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med 11: 85–89

    Article  CAS  Google Scholar 

  58. Duna GF et al. (1998) Wegener's granulomatosis: role of environmental exposures. Clin Exp Rheumatol 16: 669–674

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Drs Lori Love, Glinda Cooper, John Harley and Lisa Rider for many useful discussions and concepts in this area and we are grateful to Bradley Otterson and David Green for their technical assistance. This research was supported by the Intramural Research Program of the National Institute of Environmental Health Sciences at the NIH.

Author information

Authors and Affiliations

  1. M Gourley is a Staff Clinician in the Environmental Autoimmunity Group at the National Institute of Environmental Health Sciences, NIH, Bethesda, MD, USA, and an Associate Professor of Medicine at the George Washington School of Medicine and Health Sciences, Washington, DC, USA.,

    Mark Gourley

  2. FW Miller is the Chief of the Environmental Autoimmunity Group in the Clinical Research Center at the NIH, Bethesda.,

    Frederick W Miller

Authors
  1. Mark Gourley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Frederick W Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark Gourley.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gourley, M., Miller, F. Mechanisms of Disease: environmental factors in the pathogenesis of rheumatic disease. Nat Rev Rheumatol 3, 172–180 (2007). https://doi.org/10.1038/ncprheum0435

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0435

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing